6533b82afe1ef96bd128b74c

RESEARCH PRODUCT

X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors.

Jekaterina IvanovaJanis LeitansRaivis ZalubovskisMuhammet TancKaspars TarsKaspars TarsClaudiu T. SupuranAndris Kazaks

subject

DrugModels MolecularStereochemistryProtein Conformationmedia_common.quotation_subjectCrystallography X-RayCatalysisHydrolysischemistry.chemical_compoundCarbonic anhydraseMaterials ChemistryHumansCarbonic Anhydrase Inhibitorsmedia_commonCarbonic Anhydraseschemistry.chemical_classificationIsothiazolebiologyMetals and AlloysGeneral ChemistryLyaseSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsIsoenzymesEnzymechemistryDrug DesignX-ray crystallographyCeramics and Compositesbiology.proteinSelectivity

description

1-N-Alkylated-6-sulfamoyl saccharin derivatives were prepared and assayed as carbonic anhydrase inhibitors (CAIs). During X-ray crystallographic experiments an unexpected hydrolysis of the isothiazole ring was evidenced which allowed us to prepare highly potent enzyme inhibitors with selectivity for some isoforms with medical applications.

10.1039/c5cc01854dhttps://pubmed.ncbi.nlm.nih.gov/25813715